Scholars Central

Review articlePublished 15 Jul 2016

Manufacturing of viral vectors for gene therapy: part I. Upstream processing

Authors: Otto-Wilhelm Merten, Matthias Schweizer, Parminder Chahal, Amine A Kamen

Pharmaceutical Bioprocessing

Volume 2 · Issue 2 · Pages 183–203

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Manufacturing technologies for the production of clinical grade viral vectors have been significantly improved in recent years. This is of utmost importance for gene therapy approaches used in the treatment of inherited or acquired diseases. This article briefly describes the general principles for the production of viral vectors. The specific sections are dedicated to more detailed descriptions of the production of adenoviral, AAV, γ-retroviral and lentiviral vectors. A subsequent article (the second part) will then deal with downstream processing (purification) of viral vectors.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Pharmaceutical Bioprocessing.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPharmaceutical Bioprocessing
  • SubjectPharmaceutical Sciences
  • SubjectBiochemistry & Biotechnology
  • BylineArticles whose byline prints “Otto-Wilhelm Merten”
  • BylineArticles whose byline prints “Matthias Schweizer”
  • BylineArticles whose byline prints “Parminder Chahal”
  • BylineArticles whose byline prints “Amine A Kamen”